NASDAQ: IKT

Business

Inhibikase Therapeutics Inc (IKT): The stock’s intermediate-term indicators point to Sell today

Rosalind Gate

Inhibikase Therapeutics Inc (IKT) saw an uptrend of 4.86% in the recent trading with $1.51 being its most recent. The ...

Business

Inhibikase Therapeutics Inc (IKT): The long term indicators on the stock call for a Sell today

Heidi Phillips

Inhibikase Therapeutics Inc (IKT) saw downtrend of -1.91% in the recent trading with $1.54 being its most recent. The current ...

Baxter Report
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.